3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
30
Myelodysplastic Syndromes
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Multiple Myeloma
9
Leukemia, Myelomonocytic, Chronic
9
Primary Myelofibrosis
8
Lymphoma, Non-Hodgkin
7
Leukemia, Biphenotypic, Acute
7
Neuroblastoma
6
Myeloproliferative Disorders
6
Lymphoma
6
Hodgkin Disease
6
Burkitt Lymphoma
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Lymphoma, Large B-Cell, Diffuse
4
Ganglioneuroblastoma
4
Polycythemia Vera
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Leukemia
3
Hematologic Neoplasms
3
Thrombocythemia, Essential
2
Rhabdomyosarcoma
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell, Marginal Zone
2
Graft vs Host Disease
2
Anemia, Aplastic
2
Wilms Tumor
1
Interventions
Cyclophosphamide
12
fludarabine phosphate
7
fludarabine
7
venetoclax
6
blinatumomab
6
Cytarabine
5
Lenalidomide
4
Dexamethasone
4
Blood Specimen Collection
4
Azacitidine
4
obinutuzumab
3
Rituximab
3
Radiotherapy
3
Melphalan
3
Immunotherapy, Adoptive
3
pembrolizumab
2
daratumumab
2
Neoadjuvant Therapy
2
Idarubicin
2
Chemotherapy, Adjuvant
2
Capecitabine
2
trastuzumab deruxtecan
1
tislelizumab
1
tisagenlecleucel
1
thymoglobulin
1
tetrathiomolybdate
1
talquetamab
1
tagraxofusp
1
sacituzumab govitecan
1
sabatolimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Stem Cell Transplantation
×
1 year
×
Clear all
No trials found.